Douglas Kerr, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 880 shares at $20.72 ($18K) on 2025-12-05, disclosed to the SEC on 2025-12-05.
Scheduled sale ($18k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DYN | SELL | 2026-06-17 | $16K | — | Filing → |
| DYN | SELL | 2026-05-14 | $29K | — | Filing → |
| DYN | SELL | 2026-03-06 | $13K | — | Filing → |